295 results
Page 6 of 15
8-K
EX-99.1
d2ncf
30 Apr 13
BioTime Announces CFO Succession Plan
12:00am
8-K
EX-99.1
gs9nodrkl9mxhcn4a
23 Apr 13
LifeMap Sciences, a Subsidiary of BioTime, Announces Partnership with Appistry
12:00am
8-K
EX-99
r1or4egb49ejun
19 Apr 13
BioTime Enters into Worldwide License Agreement with UCLA to Develop Therapy for the Treatment of Stroke
12:00am
8-K
EX-99.1
8v81 skztkfjh15
10 Apr 13
LifeMap Sciences Adds Products Through Partnership with ProSpec-Tany TechnoGene
12:00am
8-K
EX-99.1
dzatsg7uizzwxnvkt
25 Mar 13
Regulation FD Disclosure
12:00am
8-K
EX-99.1
yvupe3js ut71e1uzh
18 Mar 13
BioTime Announces Fourth Quarter and Fiscal Year End 2012 Financial Results and Recent Corporate Accomplishments
12:00am
8-K
EX-99.1
wxl9hhcihd2m
13 Mar 13
BioTime to Present at 25th Annual ROTH Conference
12:00am
8-K
EX-99.1
0bgzi0q31qfvoe
12 Mar 13
BioTime Appoints Stephen C. Farrell to Board of Directors
12:00am
DEFA14A
EX-99.1
fsh 6bbh36x7
7 Mar 13
Additional proxy soliciting materials
12:00am
8-K
EX-99.1
qvfjhlp7 9p25rmih
7 Mar 13
BioTime and Romulus Agree to Accelerate Closing Date for Second Tranche of $5 Million Financing
12:00am
8-K
EX-99.1
jbkc5
4 Mar 13
BioTime and Subsidiary LifeMap Sciences Announce Data Mining Collaboration
12:00am
8-K
EX-99.1
f324gk1y2t2hfa2p5h1z
11 Feb 13
Regulation FD Disclosure
12:00am
8-K
EX-99.1
ixshm
31 Jan 13
BioTime’s Subsidiary OncoCyte Corporation Provides an Update on the Development of the Novel Pan-Cancer Diagnostic Product PanC-DxTM
12:00am
8-K
EX-99.1
i7z81xmts2 ke
30 Jan 13
Regulation FD Disclosure
12:00am
8-K
EX-99.1
dwoxlm0
18 Jan 13
BioTime CEO Dr. Michael West to Present at Scale-Up and Manufacturing of Cell-Based Therapies II Conference
12:00am
8-K
EX-99.1
yql8xy48dj 2xg1
10 Jan 13
BioTime Submits Protocol for Initiation of Human Clinical Trials of Renevia™ in Europe
12:00am
8-K
EX-99.1
8f1x0n60h vmuaekx3q
9 Jan 13
LifeMap Sciences, a Subsidiary of BioTime, Inc., Announces the Release of MalaCards Version 1.02
12:00am